(2025). An Extremely Preterm Infant With PIK3CA-Related Overgrowth Spectrum (PROS): Alpelisib Treatment and Outcome. Case Reports in Genetics.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"An Extremely Preterm Infant With PIK3CA-Related Overgrowth Spectrum (PROS): Alpelisib Treatment and Outcome."
Case Reports in Genetics 2025.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"An Extremely Preterm Infant With PIK3CA-Related Overgrowth Spectrum (PROS): Alpelisib Treatment and Outcome."
Case Reports in Genetics, 2025.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.